Madorra

Portland, United States Founded: 2014 • Age: 12 yrs
Therapeutic device for vaginal atrophy and dryness treatment is provided.

About Madorra

Madorra is a Healthcare company based in Portland (United States) founded in 2014 by Holly Rockweiler and Ryan Krone. Therapeutic device for vaginal atrophy and dryness treatment is provided. It operates on a HealthTech model. Madorra has raised $4 million across 6 funding rounds from investors including HHS, OneVentures and OTRADI. The company has 6 employees. Its chief executive, as recorded, is Holly Rockweiler. Madorra offers products and services including Nonhormonal Vaginal Health Device. Its focus areas include Medical Devices and Women's Health Devices. Its legal entity is MADORRA INC. Its competitors include Bioceptive and Impact Medical Innovations; 2 of its 2 listed competitors have raised funding.

Company details

Solutions for post-menopausal women and breast cancer survivors are developed by Madorra. A nonhormonal and noninvasive approach to treating vaginal dryness is provided, addressing moderate to severe vulvovaginal atrophy. The healthcare sector, specifically womens health, is targeted with innovative medical devices. Empowerment through choice in vaginal health management is emphasized. Breakthrough device designation status has been received for their primary solution.

  • Headquarters Portland, United States
  • Employees 6
  • Founders Holly Rockweiler, Ryan Krone
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website madorra.com
  • Social LinkedIn X Facebook
  • Legal Name Madorra Inc.
Key Metrics
  • Total Equity Funding
    $4M (USD)

    in 6 rounds

  • Latest Funding Round
    $1.51M (USD), Grant

    Sep 2024

  • Investors
    HHS

    & 3 more

  • Employee Count
    6

Products & Services of Madorra

Madorra offers a comprehensive portfolio of products and services, including Nonhormonal Vaginal Health Device.

Nonhormonal Vaginal Health Device
Medical Device

A noninvasive solution for vaginal dryness is provided.

Funding Insights of Madorra

Madorra has successfully raised a total of $4M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $1.51 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4M
  • Total Rounds 6
  • Last Round Grant — $1.51M
  • First Round $174,831

    (Jan 2016)

  • Investors Count 4

All 6 funding rounds of Madorra with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2024$1.51MGrant––
Sep 2018$4MSeries A––
Aug 2018$2.3MGrant––
Apr 2017$275,000Grant––
Mar 2017$1.42MGrant––
Jan 2016$174,831Grant––
Valuation history

4 investors in total: 4 institutional.

Investors in Madorra

Madorra has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, OneVentures and OTRADI.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital firm offering growth equity and credit for technology and healthcare companies.
one-ventures.com.au
Bioscience startups are incubated by OTRADI in Portland, Oregon.
otradi.orgPortland, United States
Venture capital fund backed by the US Government
seedfund.nsf.govAlexandria, United States
Public health and human services are overseen by HHS.
1953hhs.gov
Premium access

Investor details for Madorra

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Madorra

5 people are tracked at Madorra (4 in leadership, 1 in team); the tracked headcount is 6.

NameRoleGroup
Holly Rockweiler
Co-Founder & CEOLeadership
Ryan Krone
Co-FounderLeadership
Robert Blante
Senior Director of Operations and Manufacturing EngineeringLeadership
Bryan Flaherty
Chief Technology OfficerLeadership
Sara Lashanlo
Mechanical EngineerTeam
Premium access

Complete people profiles for Madorra

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Madorra

3 dated milestones of Madorra across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Madorra is founded.
  2. Funding First funding round of $175K.
  3. Funding Latest funding round, Grant, of $1.5M.

Competitors of Madorra

Madorra has 2 listed competitors in our database, 2 of them funded. They include Bioceptive and Impact Medical Innovations.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
bioceptive.com2010New Orleans, United States$2.94M2
Medical devices for gynecological procedures are developed.
impactmedicalinnovations.com2008Boca Raton, United States$250,000
Developer of medical device and diagnostics in point-of-care diagnostics and women’s health
Premium access

Detailed competitors of Madorra

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Women's Health & Fertility

3 companies that operate in the same segment as Madorra (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of cell-free DNA testing for oncology, women’s health, and organ health
2004Redwood City, California, United StatesUSD 152.1 MUSD 2.31 B4,430
Therapeutics for women's healthcare are developed and offered.
1997Princeton, New Jersey, United StatesUSD 123.06 MUSD 19.59 M
Provider of cell-free cancer liquid biopsy test
2015San Francisco, California, United StatesUSD 388.62 M861
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Madorra

Premium access

Complete news archive for Madorra

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madorra

Madorra was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Madorra is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.

Holly Rockweiler is the CEO of Madorra, as recorded in our data. They have also founded this company.

Madorra is a funded company, having raised a total of $4M across 6 funding rounds to date. The company's 1st funding round was a Grant of $174.83K, raised on Jan 2016.

Madorra has 6 employees.

Solutions for post-menopausal women and breast cancer survivors are developed by Madorra. A nonhormonal and noninvasive approach to treating vaginal dryness is provided, addressing moderate to severe vulvovaginal atrophy. The healthcare sector, specifically womens health, is targeted with innovative medical devices. Empowerment through choice in vaginal health management is emphasized. Breakthrough device designation status has been received for their primary solution.

Madorra's top competitors include Bioceptive and Impact Medical Innovations.

Madorra offers Nonhormonal Vaginal Health Device.

Madorra has 4 investors. Key investors include HHS, OneVentures, OTRADI, and America’s Seed Fund.

Madorra operates through Madorra Inc..

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available